Nemolizumab Long-Term Safety and Efficacy up to 148 Weeks in the OLYMPIA Open-Label Extension Study in Patients With Prurigo Nodularis. J of Skin 2026, 10 (3), s779. https://doi.org/10.25251/3gr50m60.